A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats

Kidney International

Volumn 41, Issue 1, 1992, Pages 115-123

  Van Den Born, Jacob ^a,b   Van Den Heuvel, Lambert P W J ^a   Bakker, Marinka A H ^a   Veerkamp, Jacques H ^a   Assmann, Karel J M ^a   Berden, Jo H M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ANTIBODY; HEPARAN SULFATE; MONOCLONAL ANTIBODY; NEPHRITIC FACTOR;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; GLOMERULUS MEMBRANE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMAL; ANTIBODIES, MONOCLONAL; BASEMENT MEMBRANE; BINDING SITES; HEPARAN SULFATE PROTEOGLYCAN; HEPARITIN SULFATE; KIDNEY GLOMERULUS; MALE; PROTEINURIA; PROTEOGLYCANS; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026542409     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1992.15     Document Type: Article

References (45)

1. KANWAR YS: Biophysiology of glomerular filtration and proteinuria. Lab Invest 51:7-21, 1984
2. COTRAN RS, RENNKE HG: Anionic sites and the mechanisms of proteinuria. N Engl J Med 309:1050-1052, 1983
3. FARQUHAR MG, LEMKIN MC, STOW JL: Role of proteoglycans in glomerular function and pathology, in Nephrology, edited by ROBINSON RR, New York, Springer-Verlag New York Inc., 1985, p. 580
4. PARTHASARATHY N, SPIRO RG: Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738-741, 1982
5. VERNIER RL, KLEIN DJ, SISSON SP, MAHAN JD, OEGEMA TR, BROWN DM: Heparan sulfate-rich anionic sites in the human glomerular basement membrane; decreased concentration in congenital nephrotic syndrome. N Engl J Med 309:1001-1009, 1983
6. GROGGEL GC, STEVENSON J, HOVINGH P, LINKER A, BORDER WA: Changes in heparan sulfate correlate with increased glomerular permeability. Kidney Int 33:517-523, 1988
7. SHIMOMURA H, SPIRO RG: Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes; decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374-381, 1987
8. MAHAN JD, SISSON-ROSS S, VERNIER RL: Glomerular basement membrane anionic charge site changes in aminonucleoside nephrosis. Am J Pathol 125:393-401, 1986
9. MYNDERSE LA, HASSELL JR, KLEINMAN HK, MARTIN GR, MARTINEZ-HERNANDEZ A: Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. Lab Invest 48:292-302, 1983
10. 125-I-bovine serum albumin. Lab Invest 47:177-184, 1982
11. KANWAR YS, LINKER A, FARQUHAR MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86:680-693, 1980
12. VEHASKARI VM, ROOT ER, GERMUTH FG, ROBSON AM: Glomerular charge and urinary protein excretion. Effects of systemic and intrarenal polycation infusion in the rat. Kidney Int 22:127-135, 1982
13. HUNSICKER LG, SHEARER TP, SHAFFER SJ: Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 20:7-17, 1981
14. KELLEY VE, CAVALLO T: Glomerular permeability, transfer of native ferritin in glomeruli with decreased anionic sites. Lab Invest 39:547-553, 1978
15. ASSEL E, NEUMANN K-H, SCHUREK H-J, SONNENBURG C, STOLTE H: Glomerular albumin leakage and morphology after neutralization of polyanions; I. Albumin clearance and sieving coefficient in the isolated perfused rat kidney. Renal Physiol (Basel) 7:357-364, 1984
16. SONNENBURG-HATZOPOULOS C, ASSEL E, SCHUREK HJ, STOLTE H: Glomerular albumin leakage and morphology after neutralization of polyanions; II. Discrepancy of protamine induced albuminuria and fine structure of the glomerular filtration barrier. J Submicrosc Cytol 16:741-751, 1984
17. GROGOEL GC, HOVINGH P, BORDER WA, LINKER A: Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis. Am J Pathol 128:521-527, 1987
18. LELONGT B, MAKINO H, KANWAR YS: Status of glomerular proteoglycans in aminonucleoside nephrosis. Kidney Int 31:1299-1310, 1987
19. BERTOLATUS JA, HUNSICKER LG: Polycation binding to glomerular basement membrane; effect of biochemical modification. Lab Invest 56:170-179, 1987
20. TEMPLETON DM: Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes. Lab Invest 61:202-211, 1989
21. MAKINO H, LELONGT B, KANWAR YS: Nephritogenicity of proteoglycans. II. A model of immune complex nephritis. Kidney Int 34:195-208, 1988
22. MAKINO H, GIBBONS JT, KUMUDAVALLI REDDY M, KANWAR YS: Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane. J Clin Invest 77:142-156, 1986
23. MIETTINEN A, STOW JL, MENTONE S, FARQUHAR MG: Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 163:1064-1084, 1986
24. MAKINO H, LELONGT B, KANWAR YS: Nephritogenicity of proteoglycans. III. Mechanisms of immune deposit formation. Kidney Int 34:209-219, 1988
25. KURE S, YOSHIE O: A syngeneic monoclonal antibody to murine meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): Cell density and transformation dependent alteration in cell surface HS-GAG defined by Hep-SS1. J Immunol 137:3900-3908, 1986
26. KOIKE Y, KATO M, SUZUKI S, KIMATA K: A monoclonal antibody against the heparan sulfate of EHS-tumor proteoglycan. (abstract) IX Int Symposium on Glycoconjugates B8, 1987
27. SNOW AD, MAR H, NOCHLIN D, SEKIGUCHI RT, KIMATA K, KOIKE Y, WIGHT TN: Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137:1253-1270, 1990
28. SNOW AD, WIGHT TN, NOCHLIN D, KOIKE Y, KIMATA K, DEARMOND SJ, PRUSINER SB: Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeld-Jakob disease and scrapie. Lab Invest 63:601-611, 1990
29. MEEZAN E, HJELLE JT, BRENDEL K, CARLSON EC: A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci 17:1721-1732, 1975
30. FARNDALE RW, SAVERS CA, BARRETT AJ: A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tiss Res 9:247-248, 1982
31. VAN DEN HEUVEL LPWJ, VAN DEN BORN J, VAN DE VELDEN TJAM, VEERKAMP JH, MONNENS LAH, SCHRODER CH, BERDEN JHM: Isolation and partial characterization of heparan sulfate proteoglycan from the human glomerular basement membrane. Biochem J 264:457-465, 1989
32. KOHLER G, MILSTEIN C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975
33. MANCINI O, CARBONARA AO, HEREMANS JR: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem 2:235-254, 1965
34. FAABER P, RIJKE GPM, VAN DE PUTTE LBA, CAPEL PJA, BERDEN JHM: Crossreactivity of human and murine anti-DNA antibodies with heparan sulfate: The major glycosaminoglycan in the glomerular basement membrane. J Clin Invest 77:1824-1830, 1986
35. RENNARD SI, BERO R, MARTIN GR, FOIDART JM, GEHRON ROBEY P: Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:205-210, 1980
36. LAURELL CB: Quantitative estimation of proteins of electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45-52, 1966
37. FILLIT HM, BLAKE M, MACDONALD C, MCCARTY M: Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies. J Exp Med 168:971-982, 1988
38. FILLIT H, DAMLE SP, GREGORY JD, VOLIN C, POON-KING T, ZABRISKIE J: Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med 161:277-289, 1985
39. STOW JL, SAWADA H, FARQUHAR MG: Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in the podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 82:3296-3300, 1985
40. CAMUSSI G, TETTA C, CODA R, SEGOLONI GP, VERCELLONE A: Platelet-activating factor-induced loss of glomerular anionic charges. Kidney Int 25:73-81, 1984
41. SCHMIEDEKE TMJ, STOCKL FW, WEBER R, SUGISAKI Y, BATSFORD R, VOGT A: Histones have high affinity for the glomerular basement membrane. J Exp Med 169:1879-1894, 1989
42. GARCIA-GONZALEZ M, BETTINGER S, OTT S, OLIVIER P, KADOUCHE J, POULETTY P: Purification of murine IgG3 and IgM monoclonal antibodies by euglobulin precipitation. J Immunol Meth 111:17-23, 1988
43. LIM P-L: Isolation of specific IgM monoclonal antibodies by affinity chromatography using alkaline buffers. Mol Immunol 24:11-15, 1987
44. FRIES JWU, MENDRICK DL, RENNKE HG: Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34:333-345, 1988
45. ABRASS CK, COHEN AH: Characterization of renal injury initiated by immunization of rats with heparan sulfate. Am J Pathol 130:103-111, 1988